A novel process for the preparation of tolterodine, i.e. (R)--N, N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine, in the racemic form, as well as intermediates useful for its preparation.

 
Web www.patentalert.com

< HIV replication inhibiting pyrimidines and triazines

> Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer's disease

~ 00459